Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Olin

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
The Nurse Practitioner|January 9, 2016
The Million Hearts initiative: Guidelines and best practicesBernadette Mazurek Melnyk, Liana Orsolini, Kate Gawlik, et al.
Frontiers in Pharmacology|June 4, 2021
Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical DevelopmentsMahmoud S Alghamri, Brandon L McClellan, Carson S Hartlage, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
CD200 depletion in glioma enhances antitumor immunity and induces tumor rejectionItay Raphael, Anzar A Mujeeb, Elisabet Ampudia-Mesias, et al.
Cancer Research|March 9, 2013
Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicityBrian M Andersen, G Elizabeth Pluhar, Charles E Seiler, et al.
Veterinary and Comparative Oncology|May 31, 2023
Establishment and characterization of two novel patient-derived lines from canine high-grade gliomaMorgan S Schrock, Abigail A Zalenski, Miranda M Tallman, et al.
The Journal of Clinical Investigation|December 9, 2021
Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomasHirokazu Ogino, Jennie W Taylor, Takahide Nejo, et al.
ACS Nano|May 26, 2022
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma ImmunotherapyMahmoud S Alghamri, Kaushik Banerjee, Anzar A Mujeeb, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
The Nurse Practitioner|January 9, 2016
The Million Hearts initiative: Guidelines and best practicesBernadette Mazurek Melnyk, Liana Orsolini, Kate Gawlik, et al.
Frontiers in Pharmacology|June 4, 2021
Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical DevelopmentsMahmoud S Alghamri, Brandon L McClellan, Carson S Hartlage, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
CD200 depletion in glioma enhances antitumor immunity and induces tumor rejectionItay Raphael, Anzar A Mujeeb, Elisabet Ampudia-Mesias, et al.
Cancer Research|March 9, 2013
Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicityBrian M Andersen, G Elizabeth Pluhar, Charles E Seiler, et al.
Veterinary and Comparative Oncology|May 31, 2023
Establishment and characterization of two novel patient-derived lines from canine high-grade gliomaMorgan S Schrock, Abigail A Zalenski, Miranda M Tallman, et al.
The Journal of Clinical Investigation|December 9, 2021
Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomasHirokazu Ogino, Jennie W Taylor, Takahide Nejo, et al.
ACS Nano|May 26, 2022
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma ImmunotherapyMahmoud S Alghamri, Kaushik Banerjee, Anzar A Mujeeb, et al.
Pageof 9